These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Suggestive evidence for bromocriptine-induced pleurisy. Klaassen RJ; Troost RJ; Verhoeven GT; Krepel HP; van der Lely AJ Neth J Med; 1996 Jun; 48(6):232-6. PubMed ID: 8710045 [TBL] [Abstract][Full Text] [Related]
10. [Pergolide-induced pleural effusion in a patient with juvenile parkinsonism]. Kuwabara T Rinsho Shinkeigaku; 2002 Aug; 42(8):757-60. PubMed ID: 12701223 [TBL] [Abstract][Full Text] [Related]
11. [Pravidel may cause pulmonary changes. Signs of inflammatory activity and weight loss are part of the picture]. Vinge E; Odin P; Hansson L; Widner H; Lindvall O Lakartidningen; 1994 Nov; 91(45):4116-8. PubMed ID: 7808112 [No Abstract] [Full Text] [Related]
19. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case]. Debove P; Simon F; Vaylet F; Renard JL; L'Her P Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541 [TBL] [Abstract][Full Text] [Related]
20. [The kinetics of IL-2 after pleural administration in the treatment of neoplastic pleurisy]. Astoul P; Bertault-Peres P; Durand A; Boutin C Rev Mal Respir; 1994; 11(1):29-35. PubMed ID: 8128091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]